Significance of BRAF Kinase Inhibitors for Melanoma Treatment: From Bench to Bedside

According to clinical trials, BRAF kinase inhibitors in combination with MEK kinase inhibitors are among the most promising chemotherapy regimens for the treatment of advanced BRAF-mutant melanoma, though the rate of BRAF mutation gene-bearing cutaneous melanoma is limited, especially in the Asian p...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujimura, Taku, Fujisawa, Yasuhiro, Kambayashi, Yumi, Aiba, Setsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770075/
https://www.ncbi.nlm.nih.gov/pubmed/31514399
http://dx.doi.org/10.3390/cancers11091342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770075/
https://www.ncbi.nlm.nih.gov/pubmed/31514399
http://dx.doi.org/10.3390/cancers11091342

Ejemplares similares